All Stories

  1. Letter to the Editor re: Genomic testing in paediatric urology: implications for diagnosis and management
  2. A simple technique to create pre-vascularised delivery scaffolds for organoid therapies
  3. Neurite outgrowth inhibitor-B (Nogo-B) in physiology and disease.
  4. Genetic lineage tracing identifies intermediate mesoderm as a novel contributor to mammalian kidney lymphatics
  5. Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection
  6. Microvascular aberrations found in human polycystic kidneys are an early feature in a Pkd1 mutant mouse model
  7. Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease
  8. Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis
  9. Reversal of elevatedGli3in Autosomal Recessive Polycystic Kidney Disease does not alter cystogenesis
  10. Cell Catcher: A New Method to Extract and Preserve Live Renal Cells from Urine
  11. Single‐cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney disease
  12. SGLT1 contributes to glucose-mediated exacerbation of ischemia–reperfusion injury in ex vivo rat heart
  13. Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease
  14. A unique subset of pericystic endothelium associates with aberrant microvascular remodelling and impaired blood perfusion early in polycystic kidney disease
  15. A microfluidic platform integrating functional vascularized organoids-on-chip
  16. Cell Catcher: a new method to extract and preserve live renal cells from urine
  17. Mapping the blood vasculature in an intact human kidney using hierarchical phase-contrast tomography
  18. Hyperglycemic exacerbation of myocardial infarction through SGLT1 - a glucose paradox
  19. Three-dimensional imaging and single-cell transcriptomics of the human kidney implicate perturbation of lymphatics in alloimmunity
  20. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
  21. The timing of auditory sensory deficits in Norrie disease has implications for therapeutic intervention
  22. ­­­Kidney organoids recapitulate human basement membrane assembly in health and disease
  23. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography
  24. Experimental long-term diabetes mellitus alters the transcriptome and biomechanical properties of the rat urinary bladder
  25. Identification of an Altered Matrix Signature in Kidney Aging and Disease
  26. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
  27. Mechanisms and cell lineages in lymphatic vascular development
  28. The Biological Significance and Implications of Planar Cell Polarity for Nephrology
  29. Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography
  30. Antenatal biological models in the characterization and research of congenital lower urinary tract disorders
  31. Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signalling
  32. Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis
  33. Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases
  34. Free 25-hydroxyvitamin-D concentrations are lower in children with renal transplant compared with chronic kidney disease
  35. Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease
  36. Generating Mutant Renal Cell Lines Using CRISPR Technologies
  37. Tissue Clearing and Deep Imaging of the Kidney Using Confocal and Two-Photon Microscopy
  38. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature
  39. Arterial “inflammaging” drives vascular calcification in children on dialysis
  40. SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
  41. Planar cell polarity in organ formation
  42. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury
  43. In vivo three-dimensional photoacoustic imaging of the renal vasculature in preclinical rodent models
  44. Thymosin-β4: A key modifier of renal disease
  45. Lithium induces mesenchymal-epithelial differentiation during human kidney development by activation of the Wnt signalling system
  46. HeterozygousVangl2Looptailmice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair
  47. Planar cell polarity genes Celsr1 and Vangl2 are necessary for kidney growth, differentiation, and rostrocaudal patterning
  48. Vascular growth factors play critical roles in kidney glomeruli
  49. The role of thymosin-β4 in kidney disease
  50. Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases
  51. HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
  52. Planar cell polarity and the kidney
  53. Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
  54. Albuminuria is associated with too few glomeruli and too much testosterone
  55. Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis
  56. Mechanistic Insights into Vascular Calcification in CKD
  57. Angiogenesis and autosomal dominant polycystic kidney disease
  58. The renal archaeologist: digging for clues in archived tissues to understand diabetic kidney disease
  59. Restoring the renal microvasculature to treat chronic kidney disease
  60. An unusual case of pediatric shortness of breath—questions
  61. Selective Stimulation of VEGFR2 Accelerates Progressive Renal Disease
  62. Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
  63. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation
  64. Mutations in HPSE2 Cause Urofacial Syndrome
  65. Corticosteroid-induced kidney dysmorphogenesis is associated with deregulated expression of known cystogenic molecules, as well as indian hedgehog
  66. Sphingosine kinase-1: a potential mediator of renal fibrosis
  67. Abnormal Angiogenesis in Diabetic Nephropathy
  68. Unraveling the Genetic Landscape of Bladder Development in Mice
  69. HNF1BMutations Associate with Hypomagnesemia and Renal Magnesium Wasting
  70. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism
  71. Roles of Angiopoietins in Kidney Development and Disease: Figure 1.
  72. Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4
  73. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury
  74. Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia
  75. Microarray interrogation of human metanephric mesenchymal cells highlights potentially important molecules in vivo
  76. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension
  77. Experimental short-term fetal bladder outflow obstruction: I. Morphology and cell biology associated with urinary flow impairment
  78. Vascular endothelial growth factor stimulates embryonic urinary bladder development in organ culture
  79. Human Vascular Smooth Muscle Cells Express a Urate Transporter
  80. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging
  81. IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
  82. How Does Angiotensin II Cause Renal Injury?
  83. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis